NEW PRODUCTS
[BIOSIMILAR] NEW InVivoSIM™ Antibodies (O to Z Products)
관리자
2023-05-09
Views 4,964
NEW InVivoSIM Biosimilar Antibodies (O to Z Product List)
BioXCell의 새로운 Biosimilar Antibody 제품들을 소개 합니다!!
용량(Bulk가능) 및 자세한 문의는 바이오엑스셀코리아(주)로 연락 부탁 드립니다.
| commercial
drug name |
Product Name | Isotype |
| Ofatumumab | Anti-Human CD20 Monoclonal Antibody(Ofabio) | Human IgG1-Kappa |
| Oleclumab | Anti-Human CD73 Monoclonal Antibody(Olebio) | Human IgG1(K214R/L234F/L235E/P331S)-Lambda2 |
| Olokizumab | Anti-Human IL-6 Monoclonal Antibody(Olobio) | Human IgG4(S228P)-Kappa |
| Omalizumab | Anti-Human IGHE Monoclonal Antibody(Omabio) | Human IgG1-Kappa |
| Omburtamab | Anti-Human B7-H3 Monoclonal Antibody(Ombbio) | Mouse IgG1-Kappa |
| Onvatilimab | Anti-Human VISTA Monoclonal Antibody(Onvbio) | Human IgG1-Kappa |
| Otelixizumab | Anti-Human CD3E Monoclonal Antibody(Otebio) | Human IgG1(N297A/E356D/M358L)-Lambda2(K83R) |
| Otlertuzumab | Anti-Human CD37 Monoclonal Antibody(Otlbio) | scFv-Human IgG1 Fc(E356D/M358L) |
| Ozanezumab | Anti-Human RTN4 Monoclonal Antibody(Ozabio) | Human IgG1(L235A/G237A/E356D/M358L)-Kappa |
| Ozuriftamab | Anti-Human ROR2 Monoclonal Antibody(Ozubio) | Human IgG1(E356D/M358L/KDel)-Kappa |
| Panitumumab | Anti-Human EGFR Monoclonal Antibody(Panibio) | Human IgG2-Kappa |
| Panobacumab | Anti-Human serotype IATS O11 Monoclonal Antibody(Panbio) | Human IgM-Kappa |
| Parsatuzumab | Anti-Human EGFL7 Monoclonal Antibody(Parbio) | Human IgG1-Kappa |
| Patritumab | Anti-Human HER3 Monoclonal Antibody(Patbio) | Human IgG1(K214R)-kappa |
| Penpulimab | Anti-Human PD-1 Monoclonal Antibody(Penbio) | Human IgG1(L234A/L235A/G237A/E356D/M358L)-Kappa |
| Pinatuzumab | Anti-Human CD22 Monoclonal Antibody(Pinbio) | Human IgG1(E356D/M358L)-Kappa |
| Pivekimab | Anti-Human IL-3RA Monoclonal Antibody(Pivbio) | Human IgG1(E356D/M358L/S442C/KDel)-Kappa |
| Polatuzumab | Anti--human CD79b Monoclonal Antibody(Polbio) | Human IgG1-Kappa |
| Ponezumab | Anti-Human APP Monoclonal Antibody(Ponbio) | Human IgG2(A330S/P331S)-Kappa |
| Ponsegromab | Anti-Human GDF15 Monoclonal Antibody(Ponsbio) | Human IgG1(L234A/L235A/G237A/KDel)-Kappa |
| Rilotumumab | Anti-Human HGF Monoclonal Antibody(Rilbio) | Human IgG2-Kappa |
| Robatumumab | Anti-Human IGF1R Monoclonal Antibody(Robbio) | Human IgG1(E356D/M358L)-Kappa |
| Rolinsatamab | Anti-Human PRLR Monoclonal Antibody(Rolbio) | Human IgG1(S239C)-Kappa |
| Romosozumab | Anti-Human SOST Monoclonal Antibody(Rombio) | Human IgG2-Kappa |
| Rosopatamab | Anti-Human PSMA Monoclonal Antibody(Rosbio) | Human IgG1(E356D/M358L)-Kappa |
| Rovalpituzumab | Anti-Human DLL3 Monoclonal Antibody(Rovbio) | Human IgG1(E356D/M358L/KDel)-Kappa |
| Rozanolixizumab | Anti-Human FcRn Monoclonal Antibody(Rozbio) | Human IgG4(S228P)-Kappa |
| Sabatolimab | Anti-Human Tim-3 Monoclonal Antibody(Sabbio) | Human IgG4(S228P)-Kappa |
| Sacituzumab | Anti-Human Trop-2 Monoclonal Antibody(Sacibio) | Human IgG1(K214R)-Kappa |
| Sacituzumab | Anti-Human TROP2 Monoclonal Antibody(Sacbio) | Human IgG1(E356D/M358L)-kappa |
| Sarilumab | Anti-Human IL-6R Monoclonal Antibody(Sarbio) | Human IgG1(E356D/M358L)-Kappa |
| Satralizumab | Anti-Human IL-6R Monoclonal Antibody(Satbio) | Human IgG2(C131S/R133K/E137G/C219S/H264Q/R351Q/S374A/Q415E/N430A)-Kappa |
| Selicrelumab | Anti-Human CD40 Monoclonal Antibody(Selbio) | Human IgG2-Kappa |
| Sifalimumab | Anti-Human IFNA1 Monoclonal Antibody(Sifbio) | Human IgG1-Kappa |
| Siltuximab | Anti-Human IL-6 Monoclonal Antibody(Silbio) | Human IgG1(E356D/M358L)-Kappa |
| Simtuzumab | Anti-Human LOXL2 Monoclonal Antibody(Simbio) | Human IgG4(S228P)-Kappa |
| Sintilimab | Anti-Human PD-1 Monoclonal Antibody(Sinbio) | Human IgG4 (S228P)-Kappa |
| Sofituzumab | Anti-Human MUC16 Monoclonal Antibody(Sofbio) | Human IgG1-Kappa |
| Sotigalimab | Anti-Human CD40 Monoclonal Antibody(Sotbio) | Human IgG1(S267E/E356D/M358L/KDel)-Kappa |
| Sotigalimab | Anti-Human CD40 Monoclonal Antibody(Sotibio) | Human IgG1(S267E/E356D/M358L)-Kappa |
| Sutimlimab | Anti-Human C1s Monoclonal Antibody(Sutbio) | Human IgG4(S228P/L235E)-Kappa |
| Tabalumab | Anti-Human CD257 Monoclonal Antibody(Tabbio) | Human IgG4(S228P)-Kappa(S70N) |
| Tafasitamab | Anti-Human CD19 Monoclonal Antibody(Tafbio) | Human IgG1(S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa |
| Tanezumab | Anti-Human NGF Monoclonal Antibody(Tanbio) | Human IgG2(A330S/P331S)-Kappa |
| Teplizumab | Anti-Human CD3E Monoclonal Antibody(Teplbio) | Human IgG1(L234A/L235A/E356D/M358L)-Kappa |
| Teprotumumab | Anti-Human IGF1R Monoclonal Antibody(Tepbio) | Human IgG1(E356D/M358L)-Kappa |
| Tilavonemab | Anti-Human MAPT Monoclonal Antibody(Tilbio) | Human IgG4 (S228P)-Kappa |
| Tilvestamab | Anti-Human Axl Monoclonal Antibody(Tilvbio) | Human IgG1-Kappa |
| Tinurilimab | Anti-Human CEACAM6 Monoclonal Antibody(Tinbio) | Human IgG2(KDel)-Kappa |
| Tiragolumab | Anti-Human TIGIT Monoclonal Antibody(Tirbio) | Human IgG1-Kappa |
| Tislelizumab | Anti-Human PD-1 Monoclonal Antibody(Tisbio) | Human IgG4(S228P/E233P/F234V/L235A/D265A/R409K)-Kappa |
| Toripalimab | Anti-Human PD-1 Monoclonal Antibody(Torbio) | Human IgG4 (S228P)-Kappa |
| Tovetumab | Anti-Human CD140a Monoclonal Antibody(Tovbio) | Human IgG2-Kappa |
| Tralokinumab | Anti-Human IL-13 Monoclonal Antibody(Trabio) | Human IgG4 (S228P)-Lambda2 |
| TSR-033 | Anti-Human LAG3 Monoclonal Antibody(Encbio) | Human IgG4 (S228P)-Kappa |
| Tusamitamab | Anti-Human CEACAM5 Monoclonal Antibody(Tusbio) | Human IgG1(E356D/M358L/KDel)-Kappa |
| Uliledlimab | Anti-Human NT5E Monoclonal Antibody(Ulibio) | Human IgG1(N297A)-Kappa |
| Upifitamab | Anti-Human SLC34A2 Monoclonal Antibody(Upibio) | Human IgG1(K214R/E356D/M358L)-Kappa |
| Urelumab | Anti-Human CD137 Monoclonal Antibody(Urebio) | Human IgG4 (S228P)--Kappa |
| Utomilumab | Anti-Human CD137 Monoclonal Antibody(Utobio) | Human IgG2-Lambda 2 |
| Varlilumab | Anti-Human CD27 Monoclonal Antibody(Varbio) | Human IgG4(S228P)-Kappa |
| Vedolizumab | Anti-Human α4β7 Monoclonal Antibody(Vedbio) | Human IgG1(L235A/G237A/E356D/M358L)-Kappa |
| Veltuzumab | Anti-Human CD20 Monoclonal Antibody(Velbio) | Human IgG1(K214R)-Kappa |
| Vibostolimab | Anti-Human TIGIT Monoclonal Antibody(Vibbio) | Human IgG1(E356D/M358L)-Kappa |
| Zagotenemab | Anti-Human MAPT Monoclonal Antibody(Zagbio) | Human IgG4 (S228P/F234A/L235A/K447Del)-Kappa |
| Zalutumumab | Anti-Human EGFR Monoclonal Antibody(Zalbio) | Human IgG1(K214R)-Kappa |
| Zilovertamab | Anti-Human ROR1 Monoclonal Antibody(Zilbio) | Human IgG1(E356D/M358L)-Kappa |
| Zolbetuximab | Anti-Human Claudin 18.2 Monoclonal Antibody(Zolbio) | Human IgG1-Kappa |
| Zolbetuximab | Anti-Human Claudin 18.2 Monoclonal Antibody(Zolbio) | Human IgG1(K214R)-Kappa |
- Next
- No next article.
하단영역
(ZIP code : 07532) 902, 9F Hanwha bizmetro 1-cha, 551-17 YangcheonRo,
Gayang-dong, Gangseo-Gu, Seoul, Korea
TEL : 02-2013-8240
FAX : 02-2013-8243
Email : bioxcell@bioxcell.co.kr
Copyright by 2020 BioXCell Korea. All Rights Reserved.
- BioXCell Korea
- Opening hours
- Monday - Friday 9AM - 6PM
- Follow Us
-
